Joshua Fitch, Senior Editor

According to the report, 34% of parents are using patient portals for advice regarding their child’s illness.

The approval follows a unanimous vote of support from the FDA Antimicrobial Drugs Advisory Committee of nirsevimab-alip’s favorable benefit-risk profile for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants amid their first RSV season.

The FDA has identified NOxBOX Ltd’s recall of NOxBOXi Nitric Oxide Delivery System as a Class I recall. Affected devices to the newborn and neonate patient populations can cause nitric oxide therapy interruptions because of a check valve misalignment. As of July 13, 2023, no injuries or deaths have been reported according to the federal agency.

To better protect children from its several negative effects, the Environmental Protection Agency (EPA) has proposed stricter requirements for lead-based paints in pre-1978 buildings and childcare facilities.

Despite several health and nutrition claims on breast milk substitutes and infant formula products, little to no evidence supported these claims in a multicountry study published in BMJ.

To increase access and further support healthy meals in schools across the nation, the US Department of Agriculture has dedicated millions of dollars in grants to achieve this goal.

Deep learning models have the potential to assist clinicians in determining suspicion for abusive head trauma (AHT) by screening pediatric head computed tomography (CT) images for retinal hemorrhage, according to a recent study.

Study investigators found that children with posttraumatic migraine symptoms after a concussion had higher symptom burden and lower quality of life 3 months after the injury compared to those with nonmigraine headache.

Sandra H. Jee, MD, MPH, professor of pediatrics, director, Center for Community Health and Prevention, Finger Lakes Children’s Environmental Health Center, University of Rochester Medical Center, addresses how health care institutions contribute to the climate crisis. In this Contemporary Pediatrics® interview, Jee provides practical examples health care professionals can use in their offices to better help the environment, which can better help patients in the long term.

To combat instances of e-liquid exposure and accidental ingestions among children, the FDA is offering tips for best storage and safety practices for those that regularly use and handle these products, according to a recent press release.

Improvement in the left ventricular ejection fraction (LVEF) and statistically significant benefit in the Performance of the Upper Limb (PUL v2.0) scale were observed following 2 years of CAP-1002 treatment in Duchenne muscular dystrophy (DMD) patients.

According to Italfarmaco Group, a New Drug Application (NDA) for givinostat has been accepted and granted priority review by the FDA to treat Duchenne muscular dystrophy (DMD) patients, following positive topline phase 3 trial results.

Indicated for growth hormone deficiency (GHD) patients aged 3 years and older, somatrogon-ghla is now FDA-approved to treat GHD following positive phase 3 data demonstrating non-inferiority, measured by annual height velocity at 12 months, compared to somatropin.

Nicole Peña Sahdala, MD, internist, gastroenterologist specialist in bariatric endoscopy, ABIM certified, discusses the rise in bariatric surgery among youth, and why other forms of care, such as lifestyle changes and education, are essential before any surgery is performed.

About 1 in 4 children are exposed to intimate partner violence (IPV) in their lifetime, according to the American Academy of Pediatrics. The AAP has released tips and recommendations for pediatricians to help support these patients and their families.

After Owlet’s baby-monitoring Smart Sock was pulled from the market in 2021, the FDA has cleared the company’s BabySat pulse oximetry sock for infants, capable of monitoring and alerting parents of pulse rate and oxygen saturation levels.

After receiving accelerated approval, delandistrogene moxeparvovec-rokl is the first gene therapy to treat Duchenne muscular dystrophy (DMD) in ambulatory pediatric patients aged 4 to 5 years.

In this Contemporary Pediatrics® interview, Dave Little, MD, MS, Physician Informaticist at Epic, discusses the importance of lipid screening in the pediatric population, specifically for children aged 9 to 11 years and those aged 2 to 8 years with increased risk of diabetes, obesity, or high blood pressure. Little says awareness of lipid screenings at the provider and parent levels can lead to more screenings overall, which can lead to healthier lifestyles for children.

Children 10 years and older with type 2 diabetes (T2D) can now be treated with empagliflozin and empagliflozin plus metformin hydrochloride to improve blood sugar control, per a recent approval by the FDA.

Links between teenager anxiety and gastrointestinal (GI) issues are the subject of this Contemporary Pediatrics® interview with Julia Anderson, MD, MSCI; and Sara Francis, PhD.

A family-centered procedural sedation protocol for children with autism spectrum disorder (ASD) or developmental delay (DD) allowed 93% of patients to be free of restraints during routine health care procedures.

Based on results from a recent C.S. Mott Children’s Hospital National Poll on Children’s Health, find out how comfortable parents feel when it comes to abdominal pain in their child, and how likely they are to handle the issue themselves, or to reach out to a health care provider for help.

While monitoring sleep durations (TST) across 3 different time in bed (TIB) conditions, investigators determined advancing bedtime increases sleep duration for those aged 10 to 21 years.

With a newly FDA-approved indication, odevixibat can now be used to treat cholestatic pruritus in patients 12 months and up with Alagille syndrome (ALGS).

Infant formula companies add new ingredients to match or best mimic human milk and breastfeeding advantage for the child, but comparing new-ingredient formulas with existing formulas and human milk to determine efficaciousness can present clinical and ethical challenges.

The American Medical Association is asking doctors to scale back the use of the body mass index (BMI) when assessing obesity and health in patients, noting it should be used jointly with other measurements, and not solely. 

Kirk Thame, MD, associate professor, pediatric gastroenterology, hepatology, and nutrition, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee, explains how linaclotide differs from other treatment options for pediatric functional constipation, and why children will benefit from its recent FDA approval.

Intensive lifestyle change remains the primary treatment for youth-onset type 2 diabetes. According to a study in Jama Network Open, there is more work to be done as risk perception and awareness of diabetes alone were not associated with risk-reducing behaviors.

This decision marks the first functional constipation treatment approved by the FDA for this patient population.

As children get set to head into the sun, grass, and water, now is the perfect time to remind patients and parents about best practices, treatments, and preventive measures.